Psoriasis Flashcards
Psoriasis prevalence
2%
patients with psoriasis are at increased risk of
arthritis and cardiovascular disease.
Pathophysiology psoriasis immunology?
Abnormal T cell activity stimulates keratinocyte proliferation.
There is increasing evidence this may be mediated by a novel group of T helper cells producing IL-17, designated Th17. These cells seem to be a third T-effector cell subset in addition to Th1 and Th2
Pathophysiology psoriasis genetics
associated HLA-B13, -B17, and -Cw6. Strong concordance (70%) in identical twins
Psoriasis is multifactorial and not fully understood
true
Environmental factors for psoriasis?
it is recognised that psoriasis may be worsened (e.g. Skin trauma, stress), triggered (e.g. Streptococcal infection) or improved (e.g. Sunlight) by environmental factors
Recognised subtypes of psoriasis
plaque psoriasis
flexural psoriasis
guttate psoriasis
pustular psoriasis
What is plaque psoriasis
the most common sub-type resulting in the typical well-demarcated red, scaly patches affecting the extensor surfaces, sacrum and scalp
What is flexural psoriasis
in contrast to plaque psoriasis the skin is smooth
What is guttate psoriasis
transient psoriatic rash frequently triggered by a streptococcal infection. Multiple tear drop papules on the trunk and limbs
What is pustular psoriasis
commonly occurs on the palms and soles
Complications of psoriasis?
psoriatic arthropathy (around 10%)
increased incidence of metabolic syndrome
increased incidence of cardiovascular disease
increased incidence of venous thromboembolism
psychological distress
Nail signs of psoriasis?
pitting
onycholysis
subungual hyperkeratosis
loss of nail
Psoriatic nail changes affect both fingers and toes
True
psoriatic arthropathy reflects severity of psoriasis
false
80-90% of patients with psoriatic arthropathy have nail changes
true
The following factors may exacerbate psoriasis:
trauma
alcohol
drugs: beta blockers, lithium, antimalarials (chloroquine and hydroxychloroquine), NSAIDs and ACE inhibitors, infliximab
withdrawal of systemic steroids